LT2826371T - Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius - Google Patents

Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius

Info

Publication number
LT2826371T
LT2826371T LTEP14173546.4T LT14173546T LT2826371T LT 2826371 T LT2826371 T LT 2826371T LT 14173546 T LT14173546 T LT 14173546T LT 2826371 T LT2826371 T LT 2826371T
Authority
LT
Lithuania
Prior art keywords
tellurium
compositions
methods
containing compounds
inhibiting integrins
Prior art date
Application number
LTEP14173546.4T
Other languages
English (en)
Inventor
Michael Albeck
Benjamin Sredni
Original Assignee
Feramda Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Feramda Ltd. filed Critical Feramda Ltd.
Publication of LT2826371T publication Critical patent/LT2826371T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D329/00—Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP14173546.4T 2007-11-23 2008-11-23 Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius LT2826371T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99654807P 2007-11-23 2007-11-23

Publications (1)

Publication Number Publication Date
LT2826371T true LT2826371T (lt) 2019-06-25

Family

ID=40667929

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14173546.4T LT2826371T (lt) 2007-11-23 2008-11-23 Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius

Country Status (8)

Country Link
US (2) US20100297256A1 (lt)
EP (2) EP2222167A4 (lt)
CA (1) CA2705944C (lt)
DK (1) DK2826371T3 (lt)
HR (1) HRP20190633T1 (lt)
LT (1) LT2826371T (lt)
SI (1) SI2826371T1 (lt)
WO (1) WO2009066300A2 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120157519A1 (en) * 2009-06-16 2012-06-21 Biomas Ltd. Tellerium-containing compounds for treating viral infections
AU2016224843B2 (en) * 2015-02-26 2019-12-05 Feramda Ltd. Compositions and combinations for the treatment of angiogenesis diseases and disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761490A (en) 1985-03-15 1988-08-02 Bar-Ilan University Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US4962207A (en) 1985-09-30 1990-10-09 Bar-Ilan University Organic derivatives of tellurium and selenium
US5102908A (en) * 1985-03-15 1992-04-07 Michael Albeck Method of treating Acquired Immunedeficiency Syndrome (AIDS) using organic tellurium and selenium derivatives
US5093135A (en) * 1985-09-30 1992-03-03 Michael Albeck Compounds for the induction of in vivo and in vitro production of cytokines
US4764461A (en) 1985-09-30 1988-08-16 Bar-Ilan University Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines
US4752614A (en) * 1985-09-30 1988-06-21 Bar-Ilan University Pharmaceutical compositions of tellerium and selenium compounds for the induction of in vivo and in vitro production of cytokines
US4929739A (en) 1988-03-24 1990-05-29 Bar-Ilan University Complexes of tellurium and selenium derivatives
US5213899A (en) * 1990-12-17 1993-05-25 General Electric Company Room temperature vulcanizable silicone compositions
EP1694313A4 (en) * 2003-12-18 2010-11-17 Biomas Ltd TELLURIUM DERIVATIVES FOR THE PREVENTION AND TREATMENT OF NEURODEEGENERATIVE PROCESSES
PT1715785E (pt) * 2004-01-22 2014-06-24 Biomas Ltd Métodos terapêuticos e composições farmacêuticas para tratar verrugas com compostos de telúrio
WO2006030440A2 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Use of tellurium compounds as adjuvants
WO2006030439A2 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Compositions and methods for inducing hair growth
US9216197B2 (en) * 2006-09-11 2015-12-22 Biomas Ltd. Topical formulations of tellurium-containing compounds

Also Published As

Publication number Publication date
EP2826371B1 (en) 2019-01-02
HRP20190633T1 (hr) 2019-08-23
CA2705944A1 (en) 2009-05-28
US20100297256A1 (en) 2010-11-25
DK2826371T3 (en) 2019-04-23
EP2222167A2 (en) 2010-09-01
CA2705944C (en) 2017-10-24
WO2009066300A3 (en) 2010-03-11
SI2826371T1 (sl) 2019-09-30
EP2826371A3 (en) 2015-12-30
WO2009066300A2 (en) 2009-05-28
EP2826371A2 (en) 2015-01-21
US20140194496A1 (en) 2014-07-10
EP2222167A4 (en) 2011-01-05

Similar Documents

Publication Publication Date Title
PL3812360T3 (pl) Związki monochlorotrifluoropropenu oraz kompozycje i sposoby ich zastosowania
IL214303A (en) Preparation for chemical improvement of soil
IL207519A (en) Pesticides and processes
HK1139936A1 (en) Substituted pyrimidodiazepines useful as plk1 inhibitors
IL212546A0 (en) Intumescent composition
HK1172326A1 (en) Compounds and compositions and methods of use
HK1160110A1 (en) Compounds useful for inhibiting chk1
EP2219637A4 (en) AVENANTHRAMIDE COMPOSITIONS
EP2251403A4 (en) CLEANING SUPPLIES
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
IL214664A (en) Compositions are useful for treating hair-related conditions
HK1149203A1 (en) Improved radiopharmaceutical composition
IL200383A0 (en) Neurogenic compounds
GB0715068D0 (en) Improved composition
EP2351553A4 (en) DETERGENT COMPOSITION
EP2189061A4 (en) COMPOSITION FOR WEEDING
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
EP2291335A4 (en) ANTI-CORROSIVE COMPOSITION
GB0818025D0 (en) Granular composition
EP2488183A4 (en) COMPOSITION FOR INHIBITING TGF-BETA WITH IMIDAZOPURINE DERIVATIVES
EP2224896A4 (en) VOLUMISIERUNGSZUSAMMENSETZUNGEN
EP2192904A4 (en) METHODS OF INHIBITING TGF-
GB0710574D0 (en) Antifouling composition
LT2826371T (lt) Būdai ir kompozicijos, skirti integrinų slopinimui naudojant telūro turinčius junginius
GB2455404B (en) Mild cleansing composition